Belgium· BE-AMP-SAM511226-00

Natpar 100 µg

A parathyroid hormone product containing parathyroid hormone, registered in Belgium by Shire Pharmaceuticals Ireland. The same ATC class is registered in 10 of our 19 countries.

ATC H05AA03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedNatpar 100 µgATCH05AA03REGISTER NO.BE-AMP-SAM511226-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Parathyroid hormone is registered in 10 of 19 countries.

Countries holding a registration under ATC H05AA03 (parathyroid hormone), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Parathyroid hormone · ATC H05AA03

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Parathyroid Hormone
Manufacturer
Shire Pharmaceuticals Ireland
Country
Belgium (BE)
ATC code
H05AA03
ATC class
Parathyroid hormone
Defined daily dose
0.1 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for parathyroid hormone.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Parathyroid hormone · interactions on record

5 records

  • 2 severe
  • 3 moderate

Most severe, free to view

  • DigitoxinC01AA04severe
  • DigoxinC01AA05severe
  • CalcipotriolD05AX02moderate
  • CalcitriolD05AX03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e68dd64e-39e5-497e-81a9-0ef8012c0798
GET /v1/drugs/e68dd64e-39e5-497e-81a9-0ef8012c0798?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Natpar 100 µg",
  "name_fr": "Natpar 100 µg",
  "name_nl": "Natpar 100 µg",
  "amp_code": "SAM511226-00",
  "strengths": [
    "1400.0000",
    "1400.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Parathyroid Hormone",
    "Mannitol",
    "Sodium Chloride",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Parathyroid Hormone",
  "authorisation_numbers": [
    "EU/1/15/1078/004"
  ]
}

See everything about parathyroid hormone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.